Although GM‐CSF has been commonly considered as pro‐inflammatory cytokine, recent studies have shown that in IBD, it can downregulate inflammatory responses as a part of a complex signaling cascade to restrain IBD pathogenesis.[91, 92, 93, 94]. The gene discussed is CSF2; the disease is inflammatory bowel disease.